MAP2K7 and neoplasm: We found that the use of the MEK inhibitor GSK1120212 abrogated the effect of BEZ235 on p-ERKT202/Y204 accumulation, resulting in a synergistic increase in LMS cell apoptosis and significantly higher inhibition of tumor growth.